´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 5¿ù ¿¬¼ö°Á : 2023-05-16
±³À°ÀÏÀÚ : 2023-05-16
±³À°Àå¼Ò : ´Ü±¹´ëÇб³ º´¿ø ´ë°´ç
±³À°ÁÖÁ¦ : ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 5¿ù ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÀü¤ýÃæûÁöȸ
´ã´çÀÚ : Çѹμö
¿¬¶ôó : 042-611-3151
À̸ÞÀÏ : hms43@eulji.ac.kr
±³À°Á¾·ù : ³»°ú, ÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 16ÀÏ ´ë°´ç 18:30~19:20 Current antifibrotic therapy for IPF Á¤°æÈÆ(´Ü±¹´ëÇб³º´¿ø)
Åä·Ð 05¿ù 16ÀÏ ´ë°´ç 19:20~19:30 ÅäÀÇ ( )
±³À°½Ã°£ 05¿ù 16ÀÏ ´ë°´ç 19:30~20:20 IPF and lung cancer: clinical features and management ±èµµÇü(´Ü±¹´ëÇб³º´¿ø)
Åä·Ð 05¿ù 16ÀÏ ´ë°´ç 20:20~20:30 ÅäÀÇ ( )
±³À°½Ã°£ 05¿ù 16ÀÏ ´ë°´ç 20:30~21:20 CPFE: clinical features and management ÀÌÈ£¼º(¼øõÇâ´ëÇб³Ãµ¾Èº´¿ø)
Åä·Ð 05¿ù 16ÀÏ ´ë°´ç 21:20~21:30 ÅäÀÇ ( )